Analystreport

CytomX Therapeutics (NASDAQ:CTMX) had its price target raised by analysts at HC Wainwright from $5.00 to $10.00. They now have a "buy" rating on the stock.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com